Community Practice

Latest News


CME Content


FDA has approved Striverdi Respimat (olodaterol) inhalation spray for the treatment of chronic obstructive pulmonary disease (COPD). The long-acting beta-adrenergic agonist (LABA) by Boehringer Ingelheim Pharmaceuticals can be used once daily as maintenance therapy.

Independent pharmacists will be better prepared for their new role to enhance patient care and help health plans improve their ratings under the Centers for Medicare and Medicaid (CMS) Star Rating system after attending this year’s ThoughtSpot 2014 meeting, Good Neighbor Pharmacy and AmerisourceBergen’s annual meeting in Las Vegas.

The California State Board of Pharmacy is considering new regulations that would require pharmacies throughout the state to provide translated labels on prescription drug bottles.

With evidence that more people are using it a recreational drug, the Kansas Board of Pharmacy has recommended adding promethazine with codeine syrup to the list of drugs tracked by the state.

Colchicine therapy, an effective anti-inflammatory agent for gout, is a promising treatment for preventing recurrent pericarditis. However, some patients have discontinued its use because of gastrointestinal intolerance, according to a report published online for the American Journal of Health-System Pharmacy, which will appear in the August 1 edition.

That’s the objective of many healthcare providers. Brian Isetts, a pharmacy professor at the University of Minnesota and a former policy fellow at CMS, addressed the topic at the PPSI Annual Breakfast Meeting in Orlando.

Members of the Joint Commission of Pharmacy Practitioners (JCPP) recently released a new resource document that details the patient care process. The document was developed over a two-year period and aims to “promote consistency in patient care service delivery across the profession.”